Copyright
©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 685-705
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.685
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.685
Figure 2 Molecular targets of the diabetic cardiomyopathy biomarkers in cardiomyoctes.
MAPK: Mitogen-activated protein kinase; PI3K: Phosphatidylinositol 3-kinase-protein kinase B; IGFBP7: Insulin-like growth factor binding protein 7; GLUT4: Glucose transporter type 4.
- Citation: Kumric M, Ticinovic Kurir T, Borovac JA, Bozic J. Role of novel biomarkers in diabetic cardiomyopathy. World J Diabetes 2021; 12(6): 685-705
- URL: https://www.wjgnet.com/1948-9358/full/v12/i6/685.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i6.685